Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma.

Transforming growth factor beta (TGF-beta) comprises a group of multifunctional regulatory proteins, whose effects include stimulation of extracellular matrix formation and modification of immune function. The presence of TGF-beta 1 and TGF-beta 2 in invasive breast carcinomas has been determined and related to pathological features, the presence of fibronectin and tenascin and lymphocyte/macrophage infiltration, using immunohistochemistry. Differences were observed in the extent of reactivity within the same carcinoma and between tumours stained with an antibody detecting TGF-beta 1 ane one detecting TGF-beta plus TGF-beta 2, the latter having a higher level of reactivity. Prominent reactivity for TGF-beta 1 was associated with lymph node metastasis, (0.02 > P > 0.01), increased detection of cellular fibronectin, fine stromal fibronectin staining, more prominent reactivity for tenascin (0.02 > P > 0.01), the presence of tumour-associated macrophage infiltration and altered ratios of CD4 and CD8 lymphocyte populations, with CD8 lymphocytes predominating. These associations were not observed for carcinomas showing prominent staining with antibody detecting TGF-beta 2 as well as TGF-beta 1. The findings indicate that TGF-beta 1 may have a role in invasion and metastasis of breast carcinomas.

• Publication year

  1994

• Venue

  British Journal of Cancer

• Publication date

  1994-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.1994.228PMID 7515264PMCID 1969439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo demonstration of cytoplasmic fibronectin in human breast carcinomas

  2004cited by this paper
• Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells.

  1993cited by this paper
• Alteration of stromal protein and integrin expression in breast—a marker of premalignant change?

  1992cited by this paper
• Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

  1992cited by this paper
• Transforming growth factor-beta isoforms in mammary neoplasia: more questions than answers.

  1992cited by this paper
• Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast.

  1992cited by this paper
• Localization of transforming growth factor-beta isotypes in lesions of the human breast.

  1992cited by this paper
• Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues

  1991cited by this paper
• Identification of a novel transforming growth factor-beta (TGF-beta 5) mRNA in Xenopus laevis.

  1990cited by this paper
• Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

  1990cited by this paper
• Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas–correlation with tumour differentiation

  1990cited by this paper
• Complementary deoxyribonucleic acid cloning of an mRNA encoding transforming growth factor-beta 2 from chicken embryo chondrocytes.

  1990cited by this paper
• The cell biology of transforming growth factor beta.

  1990cited by this paper
• The cell biology of transforming growth factor β

  1990cited by this paper
• Modulation of cytokine production by transforming growth factor-beta.

  1989cited by this paper
• Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts.

  1989cited by this paper
• Stromal involvement in malignant growth.

  1988cited by this paper
• Transforming growth factor-beta: possible roles in carcinogenesis.

  1988cited by this paper
• Deactivation of macrophages by transforming growth factor-beta.

  1988cited by this paper
• Tenascin: cDNA cloning and induction by TGF‐beta.

  1988cited by this paper
• A new type of transforming growth factor‐beta, TGF‐beta 3.

  1988cited by this paper
• Tenascin interferes with fibronectin action.

  1988cited by this paper
• Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes.

  1988cited by this paper
• Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma.

  1988cited by this paper
• Tenascin is a stromal marker for epithelial malignancy in the mammary gland.

  1987cited by this paper
• Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family.

  1987cited by this paper
• Expression and secretion of type beta transforming growth factor by activated human macrophages.

  1987cited by this paper
• Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

  1987cited by this paper
• Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast

  1987cited by this paper
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

  1986cited by this paper
• Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

  1986cited by this paper
• Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

  1986cited by this paper
• Human tumor-infiltrating lymphocytes: a marker of host response.

  1985cited by this paper
• Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells

  1985cited by this paper

• Hypergraph-driven spatial multimodal fusion for precise domain delineation and tumor microenvironment decoding

  2025cites this paper
• TGFβ1–TNFα-regulated secretion of neutrophil chemokines is independent of epithelial–mesenchymal transition in breast tumor cells

  2025cites this paper
• Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial

  2025cites this paper
• Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis.

  2024cites this paper
• Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos.

  2022cites this paper
• TGF-β at the crossroads of multiple prognosis in breast cancer, and beyond.

  2022cites this paper
• Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.

  2022cites this paper
• Receptor, Signal, Nucleus, Action: Signals That Pass through Akt on the Road to Head and Neck Cancer Cell Migration

  2022cites this paper
• Prognostic significance of transforming growth factor β receptor II in clinical stage III breast cancer patients - a pilot study

  2021cites this paper
• The TGFβ and Androgen Receptor Signaling Pathways Converge to Support Anoikis Resistance in Triple Negative Breast Cancer

  2021cites this paper
• B7-1 drives TGF-β stimulated pancreatic carcinoma cell migration and expression of EMT target genes

  2019cites this paper
• Adaptive Immunity in Breast Cancer Iraqian Women

  2019cites this paper
• Targeting the immunity protein kinases for immuno-oncology.

  2019cites this paper
• TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.

  2017cites this paper
• Overexpression of immunosuppressive cytokines is associated with poorer clinical stage of oral squamous cell carcinoma.

  2016cites this paper
• A dual prognostic role for the TGFβ receptors in human breast cancer.

  2016cites this paper
• Transcriptional regulation of tenascin genes

  2015cites this paper
• Oral Squamous Cell Carcinoma - Role of the Plasminogen Activation System in Tumour Progression.

  2015influential citation
• Notch Signaling Mediates Tumor-CAF Crosstalk in Basal-like Breast Cancer

  2014cites this paper
• Interaction of Immune and Cancer Cells

  2014cites this paper
• The roles of TGFβ in the tumour microenvironment

  2013cites this paper
• The prognostic role of TGF-β signaling pathway in breast cancer patients.

  2013cites this paper
• Characterising response and resistance mechanisms toFaslodex in breast cancer

  2013cites this paper
• Effects of alterations to the tumor microenvironment driven by transforming growth factor beta on tumor progression

  2013influential citation
• The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis

  2012cites this paper
• Novel Insights Into the Role of Inflammation in Promoting Breast Cancer Development

  2011cites this paper
• Differential Gene Expression Pattern of Transforming Growth Factor Beta- 1 in Early and Advanced Breast Cancers

  2011cites this paper
• Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70.

  2011cites this paper
• Molecular Differences in Sporadic Breast Cancer in Young Women (≤ 35-Year Old): Analysis of TGFBI, DDB2 and MCM5

  2011cites this paper
• How do Tumors Actively Escape from Host Immunosurveillance?

  2010cites this paper
• The regulation of tenascin expression by tissue microenvironments.

  2009cites this paper
• Tumor Suppressor and Pro-progression Roles for TGF-β in Breast Cancer

  2008cites this paper
• TGF-β1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival

  2008cites this paper
• Cancer-Associated Fibroblasts and the Role of TGF-β

  2008cites this paper
• Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study

  2008cites this paper
• Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.

  2007cites this paper
• Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer

  2007cites this paper
• Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-beta1.

  2006cites this paper
• A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.

  2006cites this paper
• Transforming growth factor-β and Smad4 regulation of invasive and metastatic behavior in cancer cells.

  2006cites this paper
• Smad4-dependent Regulation of Urokinase Plasminogen Activator Secretion and RNA Stability Associated with Invasiveness by Autocrine and Paracrine Transforming Growth Factor-β*

  2006cites this paper
• Expression of Tissue Factor in Tumor Stroma Correlates with Progression to Invasive Human Breast Cancer: Paracrine Regulation by Carcinoma Cell derived Members of the Transforming Growth Factor @3Family'

  2006cites this paper
• Determination of TGFβ1 protein level in human primary breast cancers and its relationship with survival

  2006cites this paper
• Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.

  2006cites this paper
• The multifunctional role of transforming growth factor (TGF)-ßs on mammary epithelial cell biology

  2005cites this paper
• Tumor-Mediated Suppression of Dendritic Cell Vaccines

  2005cites this paper
• Epithelial-Mesenchymal Transitions in Human Cancer

  2005cites this paper
• Relationship between major and minor salivary gland mucoepidermoid carcinoma malignancy grading and presence of stromal myofibroblasts: immunohistochemical study.

  2004cites this paper
• Linking TGF-beta-mediated Cdc25A Inhibition and Cytoskeletal Tegulation through RhoA/p160ROCK Signaling

  2004cites this paper
• Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis

  2004cites this paper
• Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro

  2004cites this paper
• Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta

  2004cites this paper
• TGFβ1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103

  2004cites this paper
• Immunosuppressive role of transforming growth factor beta in breast cancer

  2003cites this paper
• Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer.

  2003cites this paper
• Higher Stromal Expression of Transforming Growth Factor-beta Type II Receptors is Associated with Poorer Prognosis Breast Tumors

  2003cites this paper
• Computer-assisted quantitative image analysis of cell proliferation, angiogenesis and stromal markers in experimental and laryngeal tumor development

  2003cites this paper
• Tumor-Associated Macrophages in Breast Cancer

  2002cites this paper
• Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization.

  2002cites this paper
• Differential gene expression in breast cancer cell lines and stroma–tumor differences in microdissected breast cancer biopsies revealed by display array analysis

  2002cites this paper
• TGFβ Receptor Signaling in Cancer and Metastasis

  2001cites this paper
• The complexities of breast cancer desmoplasia

  2001cites this paper
• M(R) 77 KDA factor derived from fibroblasts stimulates the invasion ability of breast-cancer cells.

  2001cites this paper
• MR 77 KDA factor derived from fibroblasts stimulates the invasion ability of breast‐cancer cells

  2001cites this paper
• Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma.

  2000cites this paper
• Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in‐situ and invasive carcinomas

  2000cites this paper
• Rhodostomin inhibits the transforming growth factor-beta1-enhanced adhesion activity of ROS 17/2.8 osteosarcoma cells.

  2000cites this paper
• Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

  2000cites this paper
• Tenascin-A marker for the malignant potential of preinvasive breast cancers.

  2000cites this paper
• Tenascin patterns of expression in duct carcinoma in situ of the breast.

  2000cites this paper
• Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo.

  2000cites this paper
• Transforming growth factor beta and its receptors: their role in breast cancer

  2000cites this paper
• TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.

  2000cites this paper
• Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.

  2000cites this paper
• Statistical considerations in the methodology of quantifying immunocompetent cells in tumors.

  1999cites this paper
• Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma.

  1999cites this paper
• Transforming Growth Factor-β and Breast Cancer

  1999cites this paper
• Loss of heterozygosity of the Wilms' tumor suppressor gene (WT1) in in situ and invasive breast carcinoma.

  1999cites this paper
• Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins.

  1999cites this paper
• Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines

  1999cites this paper
• Inhibitory effects of transforming growth factor-beta1 pretreatment on experimental pulmonary metastasis of MCS-1 Chinese hamster mesenchymal chondrosarcoma cells.

  1999cites this paper
• Potential angiogenic role of platelet-activating factor in human breast cancer.

  1998cites this paper
• Activated α2-Macroglobulin Reverses the Immunosuppressive Activity in Human Breast Cancer Cell‐Conditioned Medium by Selectively Neutralizing Transforming Growth Factor-β in the Presence of Interleukin‐2

  1998cites this paper
• Growth inhibitors for mammary epithelial cells.

  1998cites this paper
• Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma

  1998cites this paper
• Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer.

  1998cites this paper
• Tumour-associated macrophages in breast cancer and their prognostic correlations

  1998cites this paper
• Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+ CD18+ cells and CD8+ CD103+ cells by multi‐epitope imaging

  1998cites this paper
• Role of transforming growth factor β3 in lymphatic metastasis in breast cancer

  1998cites this paper
• Primary biliary cirrhosis in patients with breast cancer: studying the link.

  1998cites this paper
• TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.

  1998cites this paper
• TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

  1998cites this paper
• Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.

  1997cites this paper
• Growth factors and cytokines in health and disease: Breast cancer

  1997cites this paper
• Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer.

  1997cites this paper
• Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors.

  1997cites this paper
• Molecular pathology of breast cancer and its application to clinical management

  1997cites this paper
• A molecular analysis of the oestrogen receptor and surrounding chromosomal region in early breast cancer

  1997cites this paper
• Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.

  1997cites this paper
• Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.

  1997cites this paper